Early Detection of Lung Cancer Possible with Inhalable Sensors
January 07, 2024
Massachusetts Institute of Technology has developed a groundbreaking technology that could revolutionize the diagnosis of lung cancer. The process involves inhaling nanoparticle sensors, followed by a straightforward urine test to determine the presence of a tumor. The nanosensors, administered through an inhaler or nebulizer, generate a signal if they encounter cancer-associated proteins in the lungs. This signal then accumulates in the urine, making detection possible through a basic paper test strip.
This innovative diagnostic method has the potential to either replace or complement the current standard for lung cancer diagnosis, low-dose computed tomography (CT). Particularly impactful in regions with limited access to CT scanners, such as many low- and middle-income countries, this approach represents a significant advancement in making lung cancer detection more accessible and efficient.
SOURCE: https://news.mit.edu/2024/inhalable-sensors-early-lung-cancer-detection-0105